Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:20:16.330Z.
Calculation as of: 2026-10-06T18:20:16.330Z.
Quote observation: 2026-10-06T18:17:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a29a88061d86e64317c53e71c63756e58f7ffa0b55551e6148327154cc786467
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Actuate Therapeutics Inc
Market Cap
$19.14M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.81M
Free Cash Flow Yield
N/A
TTM Avg
484.89%
3Y Avg
365.86%
5Y Avg
365.86%
Market Cap
$18.80M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.99M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.57M
Free Cash Flow Yield
N/A
TTM Avg
7.21%
3Y Avg
5.84%
5Y Avg
5.84%
Market Cap
$16.77M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $19.14M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.81M | N/A | 484.89% | 365.86% | 365.86% |
| P3 Health Partners Inc. (PIII)vs › | $18.80M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | N/A | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.74M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.57M | N/A | 7.21% | 5.84% | 5.84% |
| NextCure, Inc. (NXTC)vs › | $20.16M | N/A | 0.44% | 0.44% | 0.44% |
| Lipocine Inc. (LPCN)vs › | $17.07M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.77M | N/A | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
